Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-03
DOI
10.3389/fimmu.2022.835762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects
- (2021) Spyridoula Vasileiou et al. JOURNAL OF CLINICAL ONCOLOGY
- TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
- (2021) Nisha B. Nagarsheth et al. NATURE MEDICINE
- Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
- (2021) Karthik Dhatchinamoorthy et al. Frontiers in Immunology
- HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
- (2021) Ana Marcu et al. Journal for ImmunoTherapy of Cancer
- Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
- (2021) Shuhang Wang et al. BMC Medicine
- An engineered IL-2 partial agonist promotes CD8+ T cell stemness
- (2021) Fei Mo et al. NATURE
- Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function
- (2021) Alexander I. Salter et al. Science Signaling
- Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
- (2021) Yong-Chen Lu et al. Journal for ImmunoTherapy of Cancer
- Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
- (2021) Saisha A Nalawade et al. Journal for ImmunoTherapy of Cancer
- Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens
- (2020) Parisa Malekzadeh et al. CLINICAL CANCER RESEARCH
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
- (2020) Shelly Kalaora et al. Nature Communications
- Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
- (2020) Asmita Pal et al. Frontiers in Microbiology
- Value and affordability of CAR T-cell therapy in the United States
- (2020) Salvatore Fiorenza et al. BONE MARROW TRANSPLANTATION
- The Emerging Landscape of Immune Cell Therapies
- (2020) Evan W. Weber et al. CELL
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells
- (2020) Lun Cai et al. Frontiers in Immunology
- Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit
- (2020) Xiaobing Luo et al. Frontiers in Immunology
- The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma
- (2020) Premal D. Lulla et al. Science Translational Medicine
- CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
- (2020) Jessica Wagner et al. MOLECULAR THERAPY
- Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture
- (2020) Eleonora Ponterio et al. Frontiers in Immunology
- Coreceptors and TCR Signaling – the Strong and the Weak of It
- (2020) Alexander M. Mørch et al. Frontiers in Cell and Developmental Biology
- Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy – what are we doing; where are we going?
- (2020) Natasha Bechman et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cellular therapy against public neoantigens
- (2019) Paul M. Armistead JOURNAL OF CLINICAL INVESTIGATION
- Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
- (2019) Nirav N. Shah et al. Frontiers in Oncology
- Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
- (2019) Gal Cafri et al. Nature Communications
- Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer.
- (2019) Mikiya Ishihara et al. JOURNAL OF CLINICAL ONCOLOGY
- T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
- (2019) Smita S. Chandran et al. IMMUNOLOGICAL REVIEWS
- T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
- (2019) Aude G. Chapuis et al. NATURE MEDICINE
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- 1183PDAdoptive T cell therapy with TBI-1301 results in gene-engineered T cell persistence and anti-tumour responses in patients with NY-ESO-1 expressing solid tumours
- (2019) M O Butler et al. ANNALS OF ONCOLOGY
- Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
- (2019) Timothy T. Spear et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools
- (2019) Faviel F Gonzalez-Galarza et al. NUCLEIC ACIDS RESEARCH
- Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
- (2019) Joseph P Sanderson et al. OncoImmunology
- Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
- (2019) Indu Ramachandran et al. Journal for ImmunoTherapy of Cancer
- A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
- (2018) Hyun-Il Cho et al. BRITISH JOURNAL OF CANCER
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors
- (2018) Yong-Chen Lu et al. MOLECULAR THERAPY
- Driving T-cell immunotherapy to solid tumors
- (2018) Ken Garber NATURE BIOTECHNOLOGY
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
- (2018) Mauro P. Avanzi et al. Cell Reports
- Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells
- (2018) Daisuke Morita et al. Molecular Therapy-Methods & Clinical Development
- CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation
- (2018) Pradip Bajgain et al. Journal for ImmunoTherapy of Cancer
- Initial safety assessment of MAGE-A10c796TCR T-cells in two clinical trials.
- (2018) Vincent K. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Strategies to Address Chimeric Antigen Receptor Tonic Signaling
- (2018) Adam Ajina et al. MOLECULAR CANCER THERAPEUTICS
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- Minimal functional driver gene heterogeneity among untreated metastases
- (2018) Johannes G. Reiter et al. SCIENCE
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
- (2018) Noelle Frey et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination With or Without Ipilimumab
- (2018) Theodore S Nowicki et al. CLINICAL CANCER RESEARCH
- Improving T Cell Receptor On-Target Specificity via Structure-Guided Design
- (2018) Lance M. Hellman et al. MOLECULAR THERAPY
- The in silico human surfaceome
- (2018) Damaris Bausch-Fluck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules
- (2018) Michael T. Bethune et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
- (2018) Keisuke Watanabe et al. Frontiers in Immunology
- Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing
- (2018) Diana Campillo-Davo et al. Frontiers in Immunology
- Worldwide burden of cancer attributable to HPV by site, country and HPV type
- (2017) Catherine de Martel et al. INTERNATIONAL JOURNAL OF CANCER
- Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3
- (2017) Yong-Chen Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2017) Ifigeneia Tzannou et al. JOURNAL OF CLINICAL ONCOLOGY
- Shared cancer neoantigens: Making private matters public
- (2017) Christopher A. Klebanoff et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
- (2017) Vanessa Jurtz et al. JOURNAL OF IMMUNOLOGY
- Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
- (2017) Daniel T. Harris et al. JOURNAL OF IMMUNOLOGY
- Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
- (2017) Thomas Shum et al. Cancer Discovery
- Immune Signature of Enhanced Functional Avidity CD8+ T Cells in vivo Induced by Vaccinia Vectored Vaccine
- (2017) Zhidong Hu et al. Scientific Reports
- Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs
- (2017) Maran L. Sprouse et al. Jove-Journal of Visualized Experiments
- Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
- (2017) Melita Irving et al. Frontiers in Immunology
- HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer
- (2017) Kendra C. Foley et al. Molecular Therapy-Oncolytics
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
- (2016) Maria Parkhurst et al. CLINICAL CANCER RESEARCH
- T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
- (2016) Aude G. Chapuis et al. JOURNAL OF CLINICAL ONCOLOGY
- MAGE-C2–Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses
- (2016) Andre Kunert et al. JOURNAL OF IMMUNOLOGY
- How many TCR clonotypes does a body maintain?
- (2016) Grant Lythe et al. JOURNAL OF THEORETICAL BIOLOGY
- Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System
- (2016) Drew C Deniger et al. MOLECULAR THERAPY
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- A conserved αβ transmembrane interface forms the core of a compact T-cell receptor–CD3 structure within the membrane
- (2016) Logesvaran Krshnan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
- (2016) Jill M. Spoerke et al. Nature Communications
- Domain-swapped T cell receptors improve the safety of TCR gene therapy
- (2016) Michael T Bethune et al. eLife
- Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
- (2016) A. Pasetto et al. Cancer Immunology Research
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- CAR models: next-generation CAR modifications for enhanced T-cell function
- (2016) Daniel Abate-Daga et al. Molecular Therapy-Oncolytics
- Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
- (2015) L. M. Draper et al. CLINICAL CANCER RESEARCH
- Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
- (2015) S. Kageyama et al. CLINICAL CANCER RESEARCH
- Landscape of Tumor Antigens in T Cell Immunotherapy
- (2015) S. Ilyas et al. JOURNAL OF IMMUNOLOGY
- Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression
- (2015) Kevin J Curran et al. MOLECULAR THERAPY
- Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs
- (2015) Seok-Goo Cho et al. MOLECULAR THERAPY
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Human Tumor Antigens and Cancer Immunotherapy
- (2015) Nathalie Vigneron Biomed Research International
- Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
- (2015) Q. J. Wang et al. Cancer Immunology Research
- Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens
- (2015) Michael Hebeisen et al. Frontiers in Immunology
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes
- (2015) Veronika Vlková et al. Oncotarget
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
- (2014) A. Heczey et al. BLOOD
- Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
- (2014) T. Chodon et al. CLINICAL CANCER RESEARCH
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
- (2014) Y.-C. Lu et al. CLINICAL CANCER RESEARCH
- Survivin-specific T cell receptor targets tumor but not T cells
- (2014) Caroline Arber et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Human TCR That Incorporate CD3 Induce Highly Preferred Pairing between TCR and Chains following Gene Transfer
- (2014) Z. Sebestyen et al. JOURNAL OF IMMUNOLOGY
- Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
- (2014) Paul F. Robbins et al. JOURNAL OF IMMUNOLOGY
- TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity
- (2014) Coen Govers et al. JOURNAL OF IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- A Novel Murine T-Cell Receptor Targeting NY-ESO-1
- (2014) Shannon F. Rosati et al. JOURNAL OF IMMUNOTHERAPY
- The IPD and IMGT/HLA database: allele variant databases
- (2014) James Robinson et al. NUCLEIC ACIDS RESEARCH
- Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010
- (2014) Gulfaraz Khan et al. Infectious Agents and Cancer
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Human cell-based artificial antigen-presenting cells for cancer immunotherapy
- (2013) Marcus O. Butler et al. IMMUNOLOGICAL REVIEWS
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy
- (2013) S. Zhong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies
- (2013) Jennifer D. Stone et al. Frontiers in Immunology
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- Incorporation of Transmembrane Hydrophobic Mutations in the TCR Enhance Its Surface Expression and T Cell Functional Avidity
- (2012) A. Haga-Friedman et al. JOURNAL OF IMMUNOLOGY
- Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes
- (2012) B. Guillaume et al. JOURNAL OF IMMUNOLOGY
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
- (2012) Elena Provasi et al. NATURE MEDICINE
- Post-Transcriptional and Epigenetic Regulation of Antigen Processing Machinery (APM) Components and HLA-I in Cervical Cancers from Uighur Women
- (2012) Ayshamgul Hasim et al. PLoS One
- The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
- (2012) Christopher W. Dawson et al. SEMINARS IN CANCER BIOLOGY
- Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
- (2011) Véronique Corbière et al. CANCER RESEARCH
- Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains
- (2011) D H Aggen et al. GENE THERAPY
- A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy
- (2011) Wenbin Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
- (2011) Ulrike Gerdemann et al. MOLECULAR THERAPY
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Coexpression of the T-cell receptor constant domain triggers tumor reactivity of single-chain TCR-transduced human T cells
- (2010) R.-H. Voss et al. BLOOD
- Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy Trials
- (2010) J. L. Davis et al. CLINICAL CANCER RESEARCH
- Selected Murine Residues Endow Human TCR with Enhanced Tumor Recognition
- (2010) G. Bialer et al. JOURNAL OF IMMUNOLOGY
- Minimal Amino Acid Exchange in Human TCR Constant Regions Fosters Improved Function of TCR Gene-Modified T Cells
- (2010) D. Sommermeyer et al. JOURNAL OF IMMUNOLOGY
- A TCR Targeting the HLA-A*0201-Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer
- (2010) N. Chinnasamy et al. JOURNAL OF IMMUNOLOGY
- Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function
- (2010) D. A. Schmid et al. JOURNAL OF IMMUNOLOGY
- Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
- (2010) Takashi Inozume et al. JOURNAL OF IMMUNOTHERAPY
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Of Mice, Not Men: No Evidence for Graft-versus-Host Disease in Humans Receiving T-Cell Receptor–Transduced Autologous T Cells
- (2010) Steven A Rosenberg MOLECULAR THERAPY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mixed T cell receptor dimers harbor potentially harmful neoreactivity
- (2010) M. M. van Loenen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
- (2010) B. Guillaume et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prediction of the human membrane proteome
- (2010) Linn Fagerberg et al. PROTEOMICS
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
- (2009) K Birkholz et al. GENE THERAPY
- High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer
- (2009) Alain Bergeron et al. INTERNATIONAL JOURNAL OF CANCER
- Optimization of the PiggyBac Transposon System for the Sustained Genetic Modification of Human T Lymphocytes
- (2009) Yozo Nakazawa et al. JOURNAL OF IMMUNOTHERAPY
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- The proteasome: Overview of structure and functions
- (2009) Keiji TANAKA PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Production of soluble αβ T-cell receptor heterodimers suitable for biophysical analysis of ligand binding
- (2009) Benjamin E. Willcoj et al. PROTEIN SCIENCE
- Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: Association with disease progression
- (2009) Qiao Liu et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2-Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy
- (2009) A. B. del Campo et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity
- (2008) Jennifer D. Stone et al. IMMUNOLOGY
- CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
- (2008) L. G. Almeida et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation